Itron (ITRI) insider sale: 78 shares from vested restricted stock
Rhea-AI Filing Summary
Itron Inc (ITRI) Form 144 reports a proposed sale of 78 common shares through Fidelity Brokerage Services with an aggregate market value of $9,722.43. The filing lists 45,717,933 shares outstanding and indicates the proposed sale date as 08/11/2025 on NASDAQ. The shares were acquired on 08/08/2025 by restricted stock vesting from the issuer and were paid as compensation. The notice also discloses two prior sales by Laurie A. Hahn of 76 and 107 shares on 05/12/2025 and 05/27/2025, producing gross proceeds of $8,354.62 and $12,299.13. The signer represents no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, routine proposed sale of vested compensation shares; immaterial relative to outstanding float.
The Form 144 shows a proposed sale of 78 shares (aggregate value $9,722.43) acquired by restricted stock vesting on 08/08/2025. With approximately 45.7 million shares outstanding, this transaction is de minimis and unlikely to affect market liquidity or valuation. Prior small dispositions by Laurie A. Hahn in May (76 and 107 shares) suggest routine monetization of vested holdings rather than a significant change in insider stance. Transaction details and broker information (Fidelity) are properly disclosed.
TL;DR: Filing documents compensation-related vesting and subsequent proposed sale; disclosure aligns with Rule 144 requirements.
The filing records the acquisition as restricted stock vesting with payment characterized as compensation and a proposed Nasdaq sale via Fidelity Brokerage. The presence of prior small sales by the same individual is disclosed and gross proceeds are reported. The notice includes the standard attestation that the seller is unaware of undisclosed material adverse information, indicating procedural compliance. Given the small size of the sale relative to outstanding shares, governance implications are minimal.
FAQ
What does the ITRI Form 144 report?
How and when were the 78 shares acquired?
Who is the broker handling the proposed sale?
Were there any recent sales by the same person in the past three months?
How large is this sale relative to shares outstanding?